English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduThe qualities of flowing blood, or hemodynamics, hold important insights into vascular diseases, but technological limitations have largely kept measurements of these properties out of reach in the clinic. Now, there may be a potential solution on the horizon.
Tag: Medical Diagnostics
RNA Institute Researchers Advance DNA Nanostructure Stability
Researchers at the University at Albany’s RNA Institute have demonstrated a new approach to DNA nanostructure assembly that does not require magnesium. The method improves the biostability of the structures, making them more useful and reliable in a range of applications.
UAlbany Start-Up Receives Federal Support to Develop New Technology for Early Diagnosis of Alzheimer’s Disease
Early Alzheimer’s Diagnostics LLC was awarded a highly competitive NSF Small Business Technology Transfer grant. It will be used to advance the commercialization of a screening tool that tests saliva for the detection of early and preclinical Alzheimer’s disease.
Medical tests in the comfort of your own home: Poll shows high interest, uneven use by older adults
A new poll shows that 48% of people age 50 to 80 have bought at least one kind of at-home health test, including 32% who had bought COVID-19 tests, 17% who had bought a DNA test, and lower percentages who had bought other types of tests. But use of such direct-to-consumer medical tests varies greatly by age, race/ethnicity, marital status, income and years of education.
Rapid, at-home prototype saliva test that’s as good as RT-PCR
At-home COVID-19 tests have become an easy way to self-diagnose. But current tests have drawbacks. Now, researchers reporting in ACS Sensors have developed a SARS-CoV-2 saliva assay and prototype device that combine speed and ease with high sensitivity.
‘iTEARS’ could help diagnose diseases by isolating biomarkers in tears
In ACS Nano, researchers report a nanomembrane system that harvests and purifies tiny blobs called exosomes from tears, allowing researchers to quickly analyze them for disease biomarkers. Dubbed iTEARS, the platform could enable more efficient and less invasive diagnoses for many diseases.